Dec 15, 2019 12:53 AM
BACK TO TOP
KSE 100
40,916.59
402.42
(0.99%)
KSE ALL
29,320.16
278.41
(0.96%)
KSE 30
18,619.27
210.98
(1.15%)
KMI 30
65,149.89
937.90
(1.46%)
KMI ALL
19,251.85
263.11
(1.39%)
Otsuka Pakistan Limited
PHARMACEUTICALS
Rs.356.99
0.00
(0.00%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Dec 12, 2019 3:33 PM
REG
FUT
ODL
Open
346.75
High
356.99
Low
346.75
Volume
600
CIRCUIT BREAKER
339.15 — 374.83
DAY RANGE
346.75 — 356.99
52-WEEK RANGE
133.62 — 365.12
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
356.99
VAR
22.00
HAIRCUT
30.25
P/E Ratio (TTM)
N/A
1-Year Change *
42.28%
YTD Change *
59.02%
Open
364.00
High
364.00
Low
340.00
Close
340.00
Change
-4.76%
LDCP
356.99
Volume
5
Total Trades
2
CIRCUIT BREAKER
321.30 — 392.68
DAY RANGE
340.00 — 364.00
Ask Price
374.00
Ask Volume
1
Bid Price
340.00
Bid Volume
4
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Otsuka Pakistan Limited (the Company) was inco<porated in Pakistan as a public llmlted company Lndar the repealed Companies Ordinance, 1984 (now Companies Act, 2017). It is engaged in the manufacturing, marketing and distribution of intravenous infusions and trading in pharmaceutical products, nutrltional foods and medical equipment. The Company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan.

KEY PEOPLE
Mr. Mikio BandoChairman
Mr. Hanif SattarCEO
Mr Muhammad Amin BashirCompany Secretary
ADDRESS

30-B, Sindhi Muslim Co-operative, Housing Society, Karachi

WEBSITE

www.otsuka.pk

REGISTRAR

M/s. Central Depository Company of Pakistan Limited. CDC House, 99 – B, Block ‘B’, S.M.C.H.S., Main Shahra-e-Faisal, Karachi

AUDITOR

Deloitte Yousuf Adil (Chartered Accountants)

Fiscal Year End

June

Equity Profile

Market Cap (000's)
4,319,579.00
Shares
12,100,000
Free Float
1,709,320
Free Float
14.13%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 29, 2019TRANSMISSION OF QUARTERLY ACCOUNTS FOR THE PERIOD ENDED SEPTEMBER 30, 2019 View   PDF
Oct 22, 2019Financial Results for the Quarter Ended September 30, 2019 View   PDF
Sep 27, 2019TRANSMISSION OF ANNUAL REPORT FOR THE PERIOD ENDED JUNE 30, 2019 View   PDF
Aug 27, 2019FINANCIAL RESULTS FOR THE YEAR ENDED JUNE 30, 2019 View   PDF
Apr 29, 2019Transmission of Quarterly Accounts for the period ended March 31, 2019 View   PDF
Apr 23, 2019FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2019 View   PDF
Feb 26, 2019Condensed Interim Financial Statements for the Half-Year ended December 31, 2018 View   PDF
Feb 19, 2019FINANCIAL RESULTS FOR THE HALF-YEAR ENDED DECEMBER 31, 2018 View   PDF
Oct 31, 2018Transmission of Quarterly Accounts for the period ended September 30, 2018 View   PDF
Oct 24, 2018FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2018 View   PDF
DateTitleDocument
Oct 4, 2019Board Meeting Notice View   PDF
Oct 4, 2019Board Meeting Notice View   PDF
Sep 24, 2019Notice of Annual General Meeting View   PDF
Aug 7, 2019Board of Directors Meeting View   PDF
Apr 9, 2019Board of Directors Meeting View   PDF
Feb 4, 2019Board of Directors Meeting View   PDF
Oct 10, 2018Board Meeting Notice View   PDF
Sep 19, 2018NOTICE OF 30TH. ANNUAL GENERAL MEETING OF THE COMPANY View   PDF
Aug 15, 2018Notice of Board Meeting View   PDF
Apr 13, 2018Board of Directors Meeting View   PDF
DateTitleDocument
Sep 17, 2019Corporate Briefing Session Notice View   PDF
Nov 29, 2018Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 9, 2018Notice Transmission of e-Dividend View   PDF
Nov 7, 2018Appointment of the Chairman and Alternate Directors of the Company View   PDF
Oct 25, 2018Others View   PDF
Oct 16, 2018Publication of Notice of Election of Directors View   PDF
Aug 28, 2018Appointment of Company Secretary View   PDF
Aug 28, 2018Change in Board of Directors View   PDF
Mar 5, 2018Reappointment of Chief Executive (CEO) View   PDF
Jan 15, 2018Change of Director View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales1,884,7531,869,0131,829,6241,550,709
Profit after Taxation(175,348)65,306109,751(112,177)
EPS(14.49)5.409.98(10.20)
Q1 2020Q3 2019Q2 2019Q1 2019
Sales534,104476,029425,433441,554
Profit after Taxation25,6141,114(81,351)3,585
EPS2.120.09(6.72)0.30
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)21.0230.4927.3217.32
Net Profit Margin (%)(9.30)3.496.00(7.23)
EPS Growth (%)(368.33)(45.89)197.8423.25
PEG(1.14)0.15(0.32)

Payouts

DateFinancial ResultsDetailsBook Closure
August 28, 2018 12:35 PM30/06/2018(YR) 12% (D) 18/10/2018 - 24/10/2018
October 25, 2017 10:10 AM30/09/2017(IQ) 10% (B) 07/11/2017 - 13/11/2017
October 23, 2013 10:52 AM30/09/2013(IQ) 10%(I) (B) 07/11/2013 - 13/11/2013
October 17, 2012 11:26 AM30/09/2012(IQ) 10%(i) (D) 01/11/2012 - 07/11/2012
October 19, 2011 10:13 AM30/09/2011(IQ) 12.5%(i) (D) 01/11/2011 - 07/11/2011
October 14, 2010 10:09 AM30/09/2010(IQ) 15%(i) An Interim Dividend for the year ending June 30,2011. (D) 27/10/2010 - 02/11/2010
September 1, 2009 12:47 PM30/06/2OO9(YR) 15% (D) 08/10/2009 - 14/10/2009
August 26, 2008 12:04 PM30/06/2OO8(YR) 25% (D) 19/09/2008 - 25/09/2008
September 18, 2007 11:51 AM30/06/2OO7(YR) 25%(F) (D) 24/10/2007 - 30/10/2007
September 19, 2006 12:51 PM3O/O6/2OO6(YR) 22.5% (D) 24/10/2006 - 30/10/2006

Financial Reports